Alentis Therapeutics Raises US$105M in Series C Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Page 3 - Thomas Baumert News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Thomas Baumert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Thomas Baumert Today - Breaking & Trending Today
Alentis Therapeutics Lands $105M for Clinical Trials in Fibrosis and Cancer
Three months after Alentis Therapeutics’ lead program posted positive Phase 1 data, the biotech has raised cash to advance that program to mid-stage testing in fibrosis. The Series C financing will also support a cancer drug candidate ready to start human testing.
Source: medcitynews.com
Possible cause identified in outbreak of severe liver damage in kids
An onslaught of common childhood viruses may have been behind the mysterious outbreak of cases of severe liver damage in children that began popping up in late 2021, as lockdowns were relaxed and schools reopened.
Source: aol.com
Common viruses may be reason for hepatitis cases in children, researchers find
Last year, the World Health Organisation (WHO) reported 1,010 probable cases of liver disease worldwide - now researchers are trying to find the potential link between hepatitis and other common viruses.
Source: sky.com
Child hepatitis outbreak 'due to AAV2 virus and genes'
Strong evidence that AAV2 and underlying genetic predisposition played a key role in child hepatitis cases There is now strong evidence that the…
Source: heraldscotland.com